Charles Cotropia

Charles Cotropia

Corporate Officer/Principal presso
State Bar of Texas
Commercial Services
Consumer Services
Health Technology

Profilo

Charles S.
Cotropia
was the founder of Bioclonetics Immunotherapeutics, Inc. (founded in 2009) where he served as the Chief Executive Officer & Director from 2009 to 2020.
He is currently the President & Director at Biogenysis, Inc. and a Member of the State Bar of Texas.
Previously, he was the President, Chief Executive Officer & Director at Enzolytics, Inc. from 2020 to 2024.
He also held the position of Director at the Dallas Bar Association.
Prior to that, he worked as Senior Counsel at Sidley Austin LLP from 1973 to 2015.
Mr. Cotropia obtained his undergraduate degree from The University of Texas at Austin and his graduate degree from Cornell University.

Posizioni attive di Charles Cotropia

SocietàPosizioneInizio
Corporate Officer/Principal -

Precedenti posizioni note di Charles Cotropia

SocietàPosizioneFine
ENZOLYTICS, INC. Amministratore Delegato 19/03/2024
Presidente 23/02/2024
Fondatore 01/12/2020
Consigliere Generale 01/01/2015
Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Charles Cotropia

Formazione di Charles Cotropia

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

100 +

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

  1. Mercati
  2. Insiders
  3. Charles Cotropia
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA